The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
Primary Purpose
Thyroid Diseases, Surgery
Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
TOETVA
Sponsored by
About this trial
This is an interventional other trial for Thyroid Diseases focused on measuring TOETVA, Transoral Endoscopic Thyroidectomy Vestibular Approach
Eligibility Criteria
Inclusion Criteria:
- Patients needing surgery for: Benign or indeterminate nodule less than 6 cm in size or; T1 well differentiated papillary carcinoma less than 2 cm in size or; Well-controlled Grave's disease or; Parathyroid adenoma.
- Total thyroid size is 7-8 cm (no more than 10 cm)
- Their age is ≥18 years and ≤80 years
- Able to give written consent
Exclusion Criteria:
- - History of neck surgery or neck radiotherapy
- Recurrent thyroid disease
- Lymph node metastases
- Presence of intraoral infections
- Presence of extrathyroidal or substernal extensions
- Smoking
- Morbid obesity
- Contra-indication to general anesthesia with nasotracheal intubation
- Previous mediastinal surgery
- Any anatomical anomaly that in the opinion of the investigator may render the intervention more difficult (ex. variations in the structure of the platysmas muscle)
- Any medical condition, which in the judgment of the investigator and/or designee makes the subject a poor candidate for the investigational procedure
Sites / Locations
- Univeristy Health NetworkRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
TOETVA
Arm Description
Transoral Endoscopic Thyroidectomy Vestibular Approach
Outcomes
Primary Outcome Measures
Post-operative recurrent laryngeal nerve palsy
Number of participants with post-operative recurrent laryngeal nerve palsy
Postoperative hypocalcemia
Number of participants with postoperative hypocalcemia
Neck incision
Number of conversions to open
Rate of oral infections
Number of participants with oral infections
Rate of hematoma
Number of participants with hematomas
Rate of seroma
Number of participants with seromas
Rate of neck infection
Number of participants with neck infections
Rate of subcutaneous emphysema
Number of participants with subcutaneous emphysema
Rate of gas-induced embolism
Number of participants with gas-induced embolism
Surgical time
Surgical time in hours
Length of stay
Length of stay in days
Secondary Outcome Measures
Quality of Life Score
EORTC Thyroid specific Health related quality of life
Full Information
NCT ID
NCT04842942
First Posted
February 19, 2021
Last Updated
April 11, 2021
Sponsor
University Health Network, Toronto
1. Study Identification
Unique Protocol Identification Number
NCT04842942
Brief Title
The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
Official Title
The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
Study Type
Interventional
2. Study Status
Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
December 1, 2019 (Actual)
Primary Completion Date
December 2021 (Anticipated)
Study Completion Date
July 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Health Network, Toronto
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a single center, prospective case series designed to assess the safety and feasibility of TOETVA in a small cohort of patients at University Health Network Toronto. Included patients will undergo a TOETVA-procedure in stead of the standard open surgical procedure.
Detailed Description
Type of Study This is a single center, prospective case series
Sample Size Since this is a feasibility study we will first include 15 patients. If we find the TOETVA a safe and feasible approach, we will perform the same study in more patients using the results of this study for a power size calculation.
Study Population Patients (> 18 years) undergoing (para)thyroid surgery for the indication of a benign or indeterminate thyroid nodule, well differentiated papillary thyroid carcinoma, well-controlled Grave's disease or a parathyroid adenoma.
Study Design This is a single center, prospective case series designed to assess the safety and feasibility of TOETVA in a small cohort of patients at University Health Network Toronto. Included patients will undergo a TOETVA-procedure in stead of the standard open surgical procedure.
Study Intervention The study intervention in this study is the TOETVA-procedure. This is an Transoral Endoscopic Thyroidectomy Vestibular Approach.
Primary Objective The study objective is to assess the safety and feasibility of this procedure in a small cohort of patients at University Health Network Toronto, Ontario.
Endpoints of the study The main study endpoints consist of
Surgical Outcomes: rate of post-operative recurrent laryngeal nerve palsy, rate of post-operative hypocalcemia, and rate of neck incision (conversion to open), oral infections, neck infection, hematoma, seroma, subcutaneous emphysema, gas-induced embolism, surgical time, and length of stay.
Quality of Life - EORTC Thyroid specific Health related quality of life
These endpoints will be compared to historical age/indication controls for analysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Thyroid Diseases, Surgery
Keywords
TOETVA, Transoral Endoscopic Thyroidectomy Vestibular Approach
7. Study Design
Primary Purpose
Other
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Model Description
The study intervention in this study is the TOETVA-procedure. This is an Transoral Endoscopic Thyroidectomy Vestibular Approach.
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
TOETVA
Arm Type
Experimental
Arm Description
Transoral Endoscopic Thyroidectomy Vestibular Approach
Intervention Type
Procedure
Intervention Name(s)
TOETVA
Intervention Description
Transoral Endoscopic Thyroidectomy Vestibular Approach
Primary Outcome Measure Information:
Title
Post-operative recurrent laryngeal nerve palsy
Description
Number of participants with post-operative recurrent laryngeal nerve palsy
Time Frame
12 months
Title
Postoperative hypocalcemia
Description
Number of participants with postoperative hypocalcemia
Time Frame
12 months
Title
Neck incision
Description
Number of conversions to open
Time Frame
1 month
Title
Rate of oral infections
Description
Number of participants with oral infections
Time Frame
12 months
Title
Rate of hematoma
Description
Number of participants with hematomas
Time Frame
1 month
Title
Rate of seroma
Description
Number of participants with seromas
Time Frame
1 month
Title
Rate of neck infection
Description
Number of participants with neck infections
Time Frame
12 months
Title
Rate of subcutaneous emphysema
Description
Number of participants with subcutaneous emphysema
Time Frame
12 months
Title
Rate of gas-induced embolism
Description
Number of participants with gas-induced embolism
Time Frame
12 months
Title
Surgical time
Description
Surgical time in hours
Time Frame
until surgical discharge, average of 24 hours
Title
Length of stay
Description
Length of stay in days
Time Frame
until surgical discharge, average of 24 hours
Secondary Outcome Measure Information:
Title
Quality of Life Score
Description
EORTC Thyroid specific Health related quality of life
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- Patients needing surgery for: Benign or indeterminate nodule less than 6 cm in size or; T1 well differentiated papillary carcinoma less than 2 cm in size or; Well-controlled Grave's disease or; Parathyroid adenoma.
Total thyroid size is 7-8 cm (no more than 10 cm)
Their age is ≥18 years and ≤80 years
Able to give written consent
Exclusion Criteria:
- History of neck surgery or neck radiotherapy
Recurrent thyroid disease
Lymph node metastases
Presence of intraoral infections
Presence of extrathyroidal or substernal extensions
Smoking
Morbid obesity
Contra-indication to general anesthesia with nasotracheal intubation
Previous mediastinal surgery
Any anatomical anomaly that in the opinion of the investigator may render the intervention more difficult (ex. variations in the structure of the platysmas muscle)
Any medical condition, which in the judgment of the investigator and/or designee makes the subject a poor candidate for the investigational procedure
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jesse D Pasternak, MD
Phone
14163405195
Email
jesse.pasternak@uhn.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jesse D Pasternak, MD
Organizational Affiliation
University Health Network, Toronto
Official's Role
Principal Investigator
Facility Information:
Facility Name
Univeristy Health Network
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G2C4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jesse D Pasternak, MD
Phone
4163405195
Email
jesse.pasternak@uhn.ca
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Safety and Feasibility of Transoral Endoscopic Thyroidectomy Vestibular Approach
We'll reach out to this number within 24 hrs